Mayo Stephen 4
4 · Allogene Therapeutics, Inc. · Filed Jul 12, 2022
Insider Transaction Report
Form 4
Mayo Stephen
Director
Transactions
- Award
Common Stock
2022-07-08+35,328→ 35,328 total - Award
Stock Option (Right to Buy)
2022-07-08+54,487→ 54,487 totalExercise: $12.03Exp: 2032-07-08→ Common Stock (54,487 underlying)
Footnotes (1)
- [F1]1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant.